Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 09, 2015 08:00 ET | Source: ZS Pharma

ZS Pharma Announces New Employment Inducement Grants

SAN MATEO, Calif., Dec. 9, 2015 (GLOBE NEWSWIRE) -- ZS Pharma, Inc. (Nasdaq:SPH), today announced that on December 7, 2015 the compensation committee of its board of directors granted stock options to...
November 10, 2015 18:12 ET | Source: ZS Pharma

ZS Pharma Announces New Employment Inducement Grants

SAN MATEO, Calif., Nov. 10, 2015 (GLOBE NEWSWIRE) -- ZS Pharma, Inc. (Nasdaq:ZSPH), today announced that on November 10, 2015 the compensation committee of its board of directors granted stock options...
November 07, 2015 13:00 ET | Source: ZS Pharma

ZS Pharma Announces Positive Interim Results From a Long-Term Safety Study of ZS-9

SAN MATEO, Calif., Nov. 7, 2015 (GLOBE NEWSWIRE) -- ZS Pharma, Inc. (Nasdaq:ZSPH), today presented interim results from ZS005, a long-term safety and efficacy study of ZS-9 (sodium zirconium...
October 19, 2015 08:00 ET | Source: ZS Pharma

ZS Pharma Announces Upcoming Poster Presentation of Interim Results From Its Long-Term Safety Study of ZS-9

-- ZS005 study accepted as late-breaking poster presentation at American Society of Nephrology's Kidney Week 2015 -- -- Additional ZS-9 and hyperkalemia poster presentations also highlighted...
September 10, 2015 17:31 ET | Source: ZS Pharma

ZS Pharma Corporate Statement

SAN MATEO, Calif., Sept. 10, 2015 (GLOBE NEWSWIRE) -- ZS Pharma, Inc. (Nasdaq:ZSPH), today confirmed that it has participated in preliminary discussions with Actelion Ltd. (OTC:ALIOF) regarding a...
August 06, 2015 16:05 ET | Source: ZS Pharma

ZS Pharma Reports Second Quarter 2015 Financial Results and Provides Corporate Update

REDWOOD CITY, Calif., Aug. 6, 2015 (GLOBE NEWSWIRE) -- ZS Pharma, Inc. (Nasdaq:ZSPH), today reported its financial results for the second quarter ended June 30, 2015, and provided an overview of...
July 29, 2015 16:01 ET | Source: ZS Pharma

ZS Pharma Announces FDA Acceptance of ZS-9 New Drug Application

REDWOOD CITY, Calif., July 29, 2015 (GLOBE NEWSWIRE) -- ZS Pharma, Inc. (Nasdaq:ZSPH), today announced that its New Drug Application (NDA) for ZS-9 (sodium zirconium cyclosilicate) for the treatment...
June 16, 2015 08:00 ET | Source: ZS Pharma

ZS Pharma Names Jeffrey Farrow as Chief Financial Officer

REDWOOD CITY, Calif., June 16, 2015 (GLOBE NEWSWIRE) -- ZS Pharma, Inc. (Nasdaq:ZSPH), a biopharmaceutical company focused on the development and commercialization of highly selective, non-absorbed...
May 28, 2015 08:00 ET | Source: ZS Pharma

ZS Pharma Announces Participation at Upcoming Investor Conferences

REDWOOD CITY, Calif., May 28, 2015 (GLOBE NEWSWIRE) -- ZS Pharma, Inc. (Nasdaq:ZSPH), a biopharmaceutical company focused on the development and commercialization of highly selective, non-absorbed...
May 26, 2015 16:00 ET | Source: ZS Pharma

ZS Pharma Submits New Drug Application to U.S. Food and Drug Administration for ZS-9 for the Treatment of Hyperkalemia

REDWOOD CITY, Calif., May 26, 2015 (GLOBE NEWSWIRE) -- ZS Pharma, Inc. (Nasdaq:ZSPH), a biopharmaceutical company focused on the development and commercialization of highly selective, non-absorbed...